wanghaibo
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Different Doses of Dalpicicl Combined With Letrozole in the First-line Treatment of HR-positive, HER2-negative Advanced Breast Cancer (NCT07285382) | wanghaibo | 2025-06-25 |
Track wanghaibo automatically
Every clearance here is in the API, with alerts when new ones post.